Skip to main content

Opioid Defendants Head Back To Sixth Circuit

Opioid Defendants Head Back To Sixth Circuit

Opioid Defendants Head Back To Sixth Circuit

Introduction

Several opioids defendants, following a quiet appellate proceeding, returned to the Sixth Circuit filing a mandamus petition challenging the U.S. District Judge Dan Polster's order to produce “transactional dispensing data for the entire United States” from 2006 forward.

The petition treats MDL proceedings as exempt from the normal application of the Federal Rules of Civil Procedure. The ACLU and the U.S. Chamber of Commerce both filed amicus briefs in support of the petition. The Chamber (joined by the National Association of Chain Drug Stores), emphasized the applicability of Federal Rule 26(b)(1)’s proportionality rule, which, according to them, commands the trial judge to account for the costs and risks of producing nationwide prescription data. Meanwhile, the ACLU highlighted the serious privacy concerns of patients' medical conditions.

Also, according to the minutes of a conference placed on Friday's docket, Judge Polster pushed back the start of Cuyahoga and Summit counties' opioid trial from Oct. 13 to Nov. 9.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!